Clascoterone

柯拉特龙

Report date: 2026/05/04 20:01:27
NMEFirst In Class

Base Information

Drug NameClascoterone
Drug Alias Name克拉考特酮Cortexolone 17alpha-propionateclascoterone cream 1% w/wWinleviBreezula +[8] 
ClassificationSmall molecules
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsRosaceaAlopeciaFolliculitis +[5] 
Global Approved IndicationsAcne Vulgaris
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2020/08/26
Country/TerritoryBulgariaCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesIntrepid Therapeutics IncCassiopea Spa
China Registration ClassN/A

Develop Information

Active CompaniesCassiopea SpaSun Pharma Canada IncCosmo Spa +[7] 
Inactive CompaniesCosmo Pharmaceuticals NVStanford UniversityIntrepid Therapeutics Inc
Active IndicationsRosaceaAlopeciaFolliculitis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeG03HA
Related LinksWikipediaDrugBankKEGG